When was zPREDICTA founded?

zPREDICTA was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is zPREDICTA located?

zPREDICTA is headquartered in San Jose, United States. It is registered at San Jose, California.

How many employees does zPREDICTA have?

As of Dec 31, 2022, the latest employee count at zPREDICTA is 3.

Is zPREDICTA a funded company?

zPREDICTA is a funded company, having raised a total of $220K across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Aug 18, 2015.

When was the latest funding round of zPREDICTA?

zPREDICTA's latest funding was a $***** Seed round on 2016, with participation from 1 investor.

Where does zPREDICTA rank among its competitors?

zPREDICTA ranks 2nd amongst 16 active competitors, of which 4 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Chengdu Zhongke Aoge Biotechnology, which secured an undisclosed amount in Sep, 2025.

Who are the top competitors of zPREDICTA?

zPREDICTA's top competitors include Chengdu Zhongke Aoge Biotechnology, Yecuris and Zebrafish Lab. Among them, Chengdu Zhongke Aoge Biotechnology secured the most recent funding round in September, 2025.

zPREDICTA - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of tumor-specific in vitro 3D models for drug development. Its proprietary platform PD-3D closely mimics the human in vivo environment for drug screening assays. Its flagship range of products rBone uses the PD-3D technology to develop reconstructed bone for in vitro testing of drugs. The main application is cancer drug development.

Website: zpredicta.com
Social
Registered Address: San Jose, California

Key Metrics

Founded Year

2014

Location

San Jose, United States

Stage

Acquired

Total Funding

$220K in 2 rounds

Latest Funding Round

Seed, 2016, $*****

Investors

Y Combinator & 1 more

Ranked

2^nd among 16 active competitors

Employee Count

3 as on Dec 31, 2022

Similar Companies

Chengdu Zhongke Aoge Biotechnology & 15 more

Exit Details

Acquired by Predictive Oncology (Dec 01, 2021)

View zPREDICTA's full profile

zPREDICTA is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ZPREDICTA INC CIN: 371824897 , United States, Active	Dec 26, 999	-	3 (As on Dec 31, 2020)	-

zPREDICTA got acquired by Predictive Oncology on Dec 01, 2021.

Click here to take a look at zPREDICTA's acquisition in detail

zPREDICTA has raised a total funding of $220K over 2 rounds. Its first funding round was on Aug 18, 2015. Its latest funding round was a Seed round on 2016 for $*****. 1 investor participated in its latest round. zPREDICTA has 2 institutional investors.

Here is the list of recent funding rounds of zPREDICTA:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
2016	9696	Seed	3864	7355	3431	8806
Aug 18, 2015	5879289	Seed	8799989	9158132	7368523	Y Combinator

Access funding benchmarks and valuations. Sign up today!

View details of zPREDICTA's funding rounds and investors

The founders of zPREDICTA are Julia Kirshner and Mukti Parikh.

Here are the details of zPREDICTA's key team members:

Julia Kirshner: Co-Founder & CEO of zPREDICTA.
Mukti Parikh: Co-Founder & CTO of zPREDICTA.

View details of zPREDICTA's Founder profiles and Board Members

zPREDICTA's employee count trend

zPREDICTA has 3 employees as of Dec 22. The total employee count is 50.0% more than what it was in Dec 21. Here is zPREDICTA's employee count trend over the years:

Uncover zPREDICTA's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of zPREDICTA include Chengdu Zhongke Aoge Biotechnology, Yecuris and Zebrafish Lab. Here is the list of Top 10 competitors of zPREDICTA, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Chengdu Zhongke Aoge Biotechnology 2005, Chengdu (China), Series A	Developer of xenotransplantation technology for research purposes	$6.97M	Luminous Ventures, Betta Pharmaceuticals & 1 others	36/100
2nd	zPREDICTA 2014, San Jose (United States), Acquired	Provider of tumor-specific in vitro 3D models for drug development	$220K	Y Combinator, Propel(x)	35/100
3rd	Yecuris 2007, Tualatin (United States), Acquired	Developer of humanized liver rodent model for liver biology research	$1.25M	HHS	34/100
4th	Zebrafish Lab 2015, Noain (Spain), Funding Raised	Zebrafish based services for preclinical and environmental applications	-	EIC Fund, Sodena	29/100
5th	EpiSkin 1994, Lyon (France), Unfunded	Provider of engineered tissue focusing on human in vitro and epithelial models	-	-	29/100
6th	Xentech 2006, Paris (France), Seed	Patient-Derived tumor Xenograft patform offering preclinical cancer models and services for translational drug development	$765K	Aurinvest, Europa	29/100
7th	BrainZell 2020, Stockholm (Sweden), Seed	Developer of lab-grown cell based models of the human brain for drug development	$1.47M	Industrifonden, Creator Fund & 5 others	28/100
8th	Sagres Discovery 2000, Davis (United States), Deadpooled	Developer of mouse models to analyze disease-causing cancer genes	$20M	Forward Ventures, Walden Venture Capital & 5 others	27/100
9th	NeyroblastGX 2020, Murrieta (United States), Funding Raised	Developer of theranostic products for neurodegenerative and infectious diseases, such as Alzheimer's and COVID-19	-	National Science Foundation	27/100
10th	Invivotek 2011, Trenton (United States), Unfunded	Integrated CRO providing drug discovery and development services from target to clinical trials	-	-	27/100